Skip to main content
VATE logo

VATE · INNOVATE Corp.

Track VATE — free
$5.60 -0.01 (-0.18%) At close · Oct 23
Market Cap
$76.39M
Shares
13.64M
Volume · Oct 23 49.67K Avg daily vol (3M) 370.91K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.60 Open$5.53 Day$5.45–5.69 52W close$3.98–20.06 Avg vol 30d79K Short int555K · 4.1% float · 4.8d Short vol66% Last earningsAug 6, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 2 wks
filed Aug 6, 2026
call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.52B
Trailing 12 months
Net income (TTM)
−$22.40M
Trailing 12 months
Revenue growth YoY
+74.2%
Year over year
Operating margin
4.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
184.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$25.70M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.2%
Year over year · more shares
Price change (1Y)
+6.5%
Trailing year
Short interest
4.1%
Latest settlement · 4.8 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 19.5 · elevated Equity put/call 0.67
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −37%
below
Price vs 50-day avg −22%
below
RSI (14) 27
oversold
MACD trend Negative
52-week position 10%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −28%
trailing
6-month return −56%
trailing
YTD return +24%
this year
Relative strength −62%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $7 › 200d $9 — 200d above 50d
Institutional flow Accumulating
4 of 49 funds reported for Sep 30 · net +1.1K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.07% of float · ▼ -7.4% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
49 holders — mid 3-yr range
Squeeze score 47
elevated · 0–100
Fundamentals
Strong
Revenue growth +13%
Y/Y
Gross margin 16%
contracting
EPS growth −57%
Y/Y
Free cash flow $127.6M
Buyback $16.1M
remaining
Balance sheet $27.9M
net cash
Quant / Vol
risk profile
Very High
Volatility 113%
annualized · 1-yr
Max drawdown −72%
past year
ATR 7.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−37% Bearish
Price vs 50-day avg
−22% Bearish
RSI (14)
27 Neutral
MACD trend
Negative Bearish
52-week position
10% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $7 › 200d $9 — 200d above 50d
Institutional flow Accumulating
4 of 49 funds reported for Sep 30 · net +1.1K sh shares · +2 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.07% of float · ▼ -7.4% MoM · 4.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
49 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4 Now $6 · 10% Range high $20
vs 200-day avg -37% vs 50-day avg -22%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA - Infrastructure non-GAAP $71.7M Six Months Ended June 30, 2026 —
Adjusted EBITDA - Life Sciences non-GAAP -$2.8M Six Months Ended June 30, 2026 —
Adjusted EBITDA - Non-Operating Corporate non-GAAP -$4M Six Months Ended June 30, 2026 —
Adjusted EBITDA - Spectrum non-GAAP $1.1M Six Months Ended June 30, 2026 —
backlog 110 Q2 2026 —
DBMG adjusted backlog $2.7B As of June 30, 2026 —
DBMG Adjusted EBITDA margin non-GAAP 11.8% second quarter 2026 —
DBMG gross margin 18.5% second quarter 2026 —
DBMG reported backlog $1.9B As of June 30, 2026 —
R2 backlog 110 2Q26 —
Total Adjusted EBITDA non-GAAP $66M Six Months Ended June 30, 2026 —
Total Operating Stations 262 2Q26 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Engineering & Construction — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
VATE
INNOVATE Corp.
this stock
$76.39M +23.9% +12.5% — 4.1%
PWR
Quanta Services, Inc.
$82.15B +29.5% +13.4% 62.6 2.1%
FIX
Comfort Systems USA Inc
$40.61B +24.4% -73.9% 25.1 2.4%
FER
Ferrovial N.V.
$35.71B -23.2% — — 0.7%
EME
EMCOR Group, Inc.
$28.57B +5.9% +16.6% 20.2 1.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
50
% held
23.0%
Reported
4 of 49
Top holder
Whitefort Capital Managem…
Held Float
View
Held by Funds
Fund positions
57
View
Short & Settlement
Short Interest Falling
Shares short
555.3K
Days to cover
4.8d
Change
-44.6K sh
View
Short Volume
Short vol %
66%
As of
Oct 23, 2026
Short Total
View
Fails to Deliver
FTD shares
346
Value
$2.6K
As of
Sep 29, 2026
View
Off-Exchange
Off-exchange %
40.1%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.2B
Net income (FY)
$-60.6M
EPS diluted
$-4.84
View
Buybacks
Remaining
$16.1M
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 9, 2026
This year
23

INNOVATE Corp. amended its indenture to require redemption of all 9.500% Convertible Senior Secured Notes due 2027 on the 15th business day after the DBMG Sale lock-up ends.

View
Exempt Offerings
Offering
$360.4M
Filed
Aug 14, 2025
View
Earnings & Events
Webcasts
Last webcast
Aug 6, 2026
View
Investor Relations
Latest news
INNOVATE Completes Sale of DBM Gl…
Published
Oct 5, 2026
View

Performance

5D 20D 120D MTD YTD
VATE -6.7% -27.9% -56.2% -24.6% +23.9%
SPY -0.4% -1.5% +5.8% -0.4% +11.5%
vs SPY -6.2% -26.5% -62.0% -24.3% +12.4%

Capital returns

Buyback program · as of Jul 1, 2021
Authorized
—
Spent (derived)
—
Remaining
$16.10M

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1006837 CUSIP 45784J303 13F (30d) 3 filings 3 filers Visit website Investor relations